Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of single oral Maobushisaishinto (TJ-127) in healthy adults
jRCT1080225096Phase 1Completed
- Sponsor
- Tsumura & Co.
- Start
- Feb 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of maobushisaishinto, sponsored by Tsumura & Co. Primary endpoint: Primary pharmacokinetic parameters of TJ-127 components. Started Feb 2020; status: completed.
02
Drugs
maobushisaishinto
Beyond the preview
Go deeper on jRCT1080225096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080225096.